In a case-control analysis, use of thiazolidinediones or metformin was associated with a lower risk of developing psoriasis.

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 16-16(1)

Keywords: Acarbose, therapeutic use; Metformin, therapeutic use; Psoriasis, prevention; Sulfonylureas, therapeutic use; Thiazolidinediones, therapeutic use

Document Type: Research article

Links for this article

http://www.ingentaconnect.com/adis/inp/2008/00000001/00001637/art00039
http://openurl.ingenta.com/content?genre=article&issn=1173-8324&volume=1&issue=1637&spage=16&epage=16